Re: current CIN 3 in an immunosuppressed patient

From: Joanne Bulley (islesannie@yahoo.com)
Thu Nov 23 14:10:35 2000


I have had patients with HPV based CIN, VaIN and VIN when immunocompromised.

It seems like your patient would be an ideal one to use an anti-viral therapy. In the 'olden' days (1980's) one thing we did was use intravaginal 5-FU. We'd do 1 dose weekly for 10 weeks and repeat the pap 4-8 weeks after that. (I'll have to look up what that dose was when I get back home - I'm at my folks in OHIO now) Nowadays you have interferon and other such options.

I would probably HPV-type this woman's cervix and then treat woth some anti-viral therapy rather than whittle away at the cervix.

Joanne

At Wed, 22 Nov 2000, Ron Jewell wrote: >
>I have a renal transplant patient, nulliparous age 28 who has now had 3
>LLETZ(LEEP) procedures performed for CIN 3 over a 3 year period.
>
>Do I keep nibbling away at her cervix? Would HPV typing give any
>guidance? She wants to get pregnant in about 2 years time.
>
>All opinions are welcome. This girl intends to travel to the UK and
>Holland next year. Would anyone in the UK or in Holland like to see her
>as a patient?
>
>Regards
>Ron Jewell Bunbury Western Australia

--
Joanne Bulley, MD, FACOG
Keene, NH, USA

Take time to smell the roses.





use when must restrict search to only the ob-gyn-l forum...
Enter search keywords:
Returns per screen: Require all keywords:

Return to  OB-GYN-L Mail a New Message to the Forum: ob-gyn-l@obgyn.net
Forum Administrator: geffrey.klein@obgyn.net
Report Technical Problems: webmaster@obgyn.net
Last Updated: Mon Nov 2 04:46:23 2009

The American Medical Association is no longer designating CME hours for AMA Category II CME credit. However, physicians themselves may self designate learning activities as Category II CME credit hours if they feel it is of sufficient educational merit and meets the formal definitions of continuing medical education. OBGYN.net believes these interaction in this forum meets these criteria. For further information see the AMA web site.